NASA has confirmed that the agency, in coordination with SpaceX, is targeting no earlier than 5 p.m. Eastern Time (2200 GMT) on Wednesday, January 14, for the undocking of the SpaceX Crew-11 mission from the International Space Station (ISS). The planned departure remains dependent on favorable weather conditions, which are a key factor in ensuring a safe return to Earth for the astronauts aboard the mission.
The announcement comes amid heightened attention after NASA disclosed earlier this week that it was considering an early return of the ISS crew due to what the agency described as a “medical concern” involving one of the astronauts. While NASA has not released specific details regarding the nature of the medical issue, officials emphasized that the health and safety of the crew remain the top priority and that contingency plans are a routine part of human spaceflight operations.
The SpaceX Crew-11 mission is part of NASA’s Commercial Crew Program, which relies on SpaceX’s Crew Dragon spacecraft to transport astronauts to and from the ISS. The mission has been docked at the orbiting laboratory while the crew carried out a range of scientific experiments, technology demonstrations, and station maintenance tasks critical to ongoing space research.
NASA stated that mission managers are continuing to closely monitor the astronaut’s condition, overall crew readiness, spacecraft performance, and weather patterns at the designated splashdown zones. Any changes to the undocking timeline will be communicated as more information becomes available.
The potential early undocking highlights the flexibility built into modern space missions, allowing agencies like NASA and partners such as SpaceX to respond quickly to unforeseen situations. As the target date approaches, space enthusiasts and industry observers will be watching closely for updates on the Crew-11 return, the astronaut’s health status, and how the mission concludes.
For now, NASA maintains that the January 14 undocking window remains the earliest opportunity, pending final assessments, underscoring the careful balance between mission objectives and astronaut well-being in human spaceflight.


Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
C3.ai in Merger Talks With Automation Anywhere as AI Software Industry Sees Consolidation
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Google Halts UK YouTube TV Measurement Service After Legal Action
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 



